Teva CEO Jeremy Levin Unexpectedly Steps Down

Teva CEO Jeremy Levin Unexpectedly Steps Down Play

Oct. 30 (Bloomberg) -- Bloomberg Middle East Editor Elliott Gotkine reports that Teva Pharmaceuticals CEO Jeremy Levin has stepped down after less than 18 months on the job following a reported feud with Chairman Philip Frost. He speaks on Bloomberg Television’s “The Pulse.”

  • On Air Now

    The Great Disrupters: Businessweek Anniversary Watch Now

  • Next

    2015 Surveillance

blog comments powered by Disqus